老年人群低丙氨酸氨基转移酶水平与衰弱、失能、肌少症及生存率降低相关
基于InCHIANTI前瞻性人群数据库765名65岁以上无慢性肝病、恶性肿瘤或酗酒者,分析ALT与衰弱、失能、肌少症及死亡的关系。ALT活性与衰弱、肌少症、失能和吡哆醇缺乏呈负相关,且经多变量调整后较高ALT仍与全因和心血管死亡风险降低独立相关,呈J型非线性关系。
要点
- 老年人低ALT水平与衰弱、肌少症、失能及吡哆醇缺乏相关。
- ALT与死亡率呈J型关系,最低五分位组全因和心血管死亡率急剧升高。
核心结论
- 老年人ALT水平降低可作为衰弱、失能和肌少症的标志物,并独立预测不良结局。
研究设计与样本
- 数据来自InCHIANTI前瞻性人群数据库,纳入765名65岁以上参与者(平均年龄75.3岁,女性61.8%),排除慢性肝病、恶性肿瘤或酗酒者。
- 衰弱按Fried标准定义,肌少症通过外周定量CT测量(以身高和脂肪质量回归肌肉质量残差的最低性别特异性三分位定义),失能定义为自报至少一项基本日常生活活动需要帮助。
- ALT与全因及心血管死亡的关系采用含时变协变量的Cox模型评估。
主要发现
- ALT活性与衰弱、肌少症、失能和吡哆醇缺乏呈负相关。
- ALT与死亡率关系呈非线性(J型),ALT水平最低五分位组全因和心血管死亡率急剧升高。
关键数值与推荐
- 衰弱定义采用Fried标准。
- 肌少症定义为外周定量CT测得肌肉质量残差的最低性别特异性三分位。
- 失能定义为自报至少一项基本日常生活活动需要帮助。
临床怎么用
- 在老年综合评估中,低ALT水平可提示衰弱、失能和肌少症风险,并应关注其与不良生存结局的关联。
- 对于ALT水平处于最低五分位的老年人,可考虑进一步评估衰弱、失能和肌少症状态。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although low alanine aminotransferase (ALT) levels have been associated with poor outcomes in the elderly population, the determinants subtending this association have been poorly explored. To gain insight into this topic, we analyzed data from a prospective population-based database (InCHIANTI study) in which frailty, disability, sarcopenia, and pyridoxine levels were systematically assessed. METHODS: Data are from 765 participants aged more than 65 years (mean age 75.3 years, women 61.8%), without chronic liver disease, malignancies, or alcohol abuse. Frailty was defined according to Fried criteria, sarcopenia through peripheral Quantitative-Computed-Tomography (lowest gender-specific tertile of the residuals of a linear regression of muscle mass from height and fat mass), and disability as self-reported need for help in at least one basic daily living activity. Associations of ALT with overall and cardiovascular mortality were assessed by Cox-models with time-dependent covariates. RESULTS: ALT activity was inversely associated with frailty, sarcopenia, disability, and pyridoxine deficiency; however, higher ALT was confirmed to be protective with respect of overall and cardiovascular mortality even in multiple-adjusted models including all these covariates (overall: hazard ratio [HR] 0.98 [0.96-1], p = .02; cardiovascular: 0.94 [0.9-0.98], p < .01). The association between ALT activity and mortality was nonlinear (J-shaped), and subjects in the lower quintiles of ALT levels showed a sharply increased overall and cardiovascular mortality. CONCLUSIONS: These results suggest that reduced ALT levels in older individuals can be considered as a marker of frailty, disability, and sarcopenia, and as an independent predictor of adverse outcomes. The possible relationship between reduced ALT and impaired hepatic metabolic functions should be explored.
引用
- Vespasiani-Gentilucci U, De Vincentis A, Ferrucci L, et al. Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival. J Gerontol A Biol Sci Med Sci. 2018. PMID: 28633440. doi:10.1093/gerona/glx126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。